MiMedx Raises $150M To Scale Advanced Wound Care Product Biz

Wound care company MiMedx has raised $150m in private equity and debt financing from EW Healthcare Partners and Hayfin Capital Management. The funds will be used to scale commercialization of the company’s amniotic tissue products.

Dollar bills

MiMedx Group, Inc. has raised $150m in private equity and debt financing to scale commercialization of its advanced wound care products, marking a vote of confidence in the company’s new C-suite team.

MiMedx’s core business develops amniotic tissue products. The company uses a manufacturing process to transform human placental tissue into a variety of skin substitute products that promote skin healing for...

More from Financing

More from Business